Propanc Biopharma, a Nasdaq-listed biotech firm, has secured up to $100 million to bolster its digital asset strategy.
Home / Biotech firm Propanc secures $100m for digital asset acquisition
Propanc Biopharma, a Nasdaq-listed biotech firm, has secured up to $100 million to bolster its digital asset strategy.
Saipan woman Sze Man Yu Inos gets 71 months in prison for bitcoin fraud targeting seniors, with $769,355 in restitution
Bitbank launches EPOS Crypto Card in Japan, letting users settle bills with bitcoin from exchange balances and earn 0.5% crypto
Senator Thom Tillis has threatened to oppose the Senate’s crypto market structure bill unless ethics restrictions on White House crypto